David Scott Jones

Business address
C/O Eyepoint Pharmaceuticals, Inc.,, 480 Pleasant Street, Suite A210, Watertown, MA, 02472
Top holdings (ownership)
EYPT
Get insider transactions for this reporting owner
David Scott Jones has filed 21 SEC EDGAR filings since 12 Jun 2019

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing PRIMARY DOCUMENT 13 Feb 2024 09 Feb 2024 000-51122
4 Open Document Open Filing PRIMARY DOCUMENT 05 Feb 2024 02 Feb 2024 000-51122
144 Open Document Open Filing 02 Feb 2024
4 Open Document Open Filing PRIMARY DOCUMENT 29 Jan 2024 26 Jan 2024 000-51122
4 Open Document Open Filing PRIMARY DOCUMENT 26 Jan 2024 24 Jan 2024 000-51122
4 Open Document Open Filing PRIMARY DOCUMENT 24 Jan 2024 22 Jan 2024 000-51122
144 Open Document Open Filing 24 Jan 2024
144 Open Document Open Filing 22 Jan 2024
4 Open Document Open Filing PRIMARY DOCUMENT 09 Jan 2024 05 Jan 2024 000-51122
4 Open Document Open Filing PRIMARY DOCUMENT 22 Jun 2023 20 Jun 2023 000-51122
4 Open Document Open Filing PRIMARY DOCUMENT 13 Feb 2023 09 Feb 2023 000-51122
4 Open Document Open Filing PRIMARY DOCUMENT 10 Jan 2023 06 Jan 2023 000-51122
4 Open Document Open Filing PRIMARY DOCUMENT 02 Mar 2022 28 Feb 2022 000-51122
4 Open Document Open Filing PRIMARY DOCUMENT 11 Feb 2022 09 Feb 2022 000-51122
4 Open Document Open Filing PRIMARY DOCUMENT 03 Nov 2021 01 Nov 2021 000-51122
4 Open Document Open Filing PRIMARY DOCUMENT 23 Jun 2021 22 Jun 2021 000-51122
4 Open Document Open Filing PRIMARY DOCUMENT 02 Mar 2021 28 Feb 2021 000-51122
4 Open Document Open Filing PRIMARY DOCUMENT 02 Jul 2020 30 Jun 2020 000-51122
4 Open Document Open Filing PRIMARY DOCUMENT 03 Mar 2020 28 Feb 2020 000-51122
4 Open Document Open Filing PRIMARY DOCUMENT 12 Jun 2019 10 Jun 2019 000-51122
3 Open Document Open Filing PRIMARY DOCUMENT 12 Jun 2019 10 Jun 2019 000-51122